Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-10-02

Clinical Trial Update: Propofol Versus Dexmedetomidine Effect on Prevention Emergence Agitation [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing propofol and dexmedetomidine for prevention of emergence agitation has completed. The sponsor is Ain Shams University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)
  • PROPOFOL (Propofol)

Snippet

Sponsor: Ain Shams University | Conditions: Emergence Agitation | Phase 4 | Status: COMPLETED